Fig. 5.
a Coronal images of positive lymph node on 64Cu-TP3805 which was proven malignant by histology. b Comparison of 64Cu-TP3805 DAR analysis of malignant and benign lymph nodes versus histologic H&E analysis. Top—uptake of 64Cu-TP3805 in prostate cancer foci in a malignant lymph node. Bottom—no uptake of 64Cu-TP3805 in benign node (This research was originally published in Tripathi et al. [28])